Biomedix, a leader in advanced diagnostic technology in vascular health, is proud to announce the donation of its cutting-edge PADnet 5th generation device, PADnet Xpress, and accompanying digital health assessments to the New York College of Podiatric Medicine (NYCPM). This donation underscores Biomedix’s commitment to advancing education, clinical research, and patient care in the field of podiatric medicine.
The PADnet 5th generation device and PADnet Xpress, which offer state-of-the-art diagnostic capabilities, will be integrated into the educational and clinical training programs at NYCPM. These devices are designed to provide real-time, non-invasive peripheral artery disease (PAD) assessments, helping to diagnose and manage vascular health issues in patients with diabetes and other risk factors for PAD.
“We are excited to support NYCPM’s mission to advance podiatric education and clinical excellence,” said Chris Trygstad, Vice President of Product at Biomedix. “The PADnet 5th generation and PADnet Xpress devices are powerful tools in the early detection of PAD, a condition that affects millions of people worldwide. By providing these technologies to NYCPM, we hope to empower the next generation of podiatric practitioners with the latest diagnostic tools and enhance their ability to provide optimal care to their patients.”
Dr. Trepal, Dean of the New York College of Podiatric Medicine and Surgery, expressed enthusiasm for the donation, stating, “This generous donation from Biomedix will significantly enhance our educational programs and research initiatives. The PADnet technology aligns with our mission to provide our students with hands-on experience using the latest medical devices and techniques. We are confident that the integration of PADnet will contribute to the training of skilled podiatrists who are better equipped to address the growing prevalence of peripheral artery disease.”
The donation will support both the clinical training of students and research in the growing field of vascular health, positioning NYCPM as a leader in podiatric education and care. With the increasing prevalence of PAD, especially in patients with diabetes and other chronic conditions, the ability to diagnose and monitor this condition is critical to improving long-term health outcomes.
Biomedix is committed to supporting the advancement of podiatric medicine through innovation, education, and community partnerships. The company’s ongoing collaboration with medical institutions, such as NYCPM, helps ensure that the latest diagnostic tools are accessible to both healthcare providers and patients.
About New York College of Podiatric Medicine and Surgery (NYCPM):
The New York College of Podiatric Medicine and Surgery (NYCPM) is a premier educational institution dedicated to advancing the field of podiatric medicine. Located in New York City, NYCPM offers comprehensive programs for students to gain in-depth knowledge and practical experience in podiatric medicine, surgery, and research. The college is committed to improving the health and well-being of individuals through education, research, and clinical care.
About Biomedix
Biomedix is a leading provider of front-line diagnostic solutions committed to delivering value-based care. The company’s mission is to enhance the quality of healthcare through innovative mobile health assessment platforms that centralize data for comprehensive population health analysis across multiple chronic conditions. Biomedix supports a variety of diagnostic devices to empower healthcare providers with the tools necessary for accurate and efficient patient assessments.
Biomedix values innovation, integrity, and collaboration. The company’s solutions are designed to improve patient outcomes by providing actionable insights and facilitating coordinated care. By integrating advanced technology with user-friendly interfaces, Biomedix strives to make healthcare more accessible and effective for both providers and patients. The dedication to excellence and continuous improvement drives the development of solutions that meet the evolving needs of the healthcare industry.
Biomedix media contact:
Chris Trygstad
VP, Product
